Why the study?
Does cardiomyocyte-specific overexpression of human stem cell factor improve cardiac function and survival after myocardial infarction in mice?
Does cardiomyocyte-specific overexpression of human stem cell factor improve cardiac function and survival after myocardial infarction in mice?
Cardiomyocyte-specific overexpression of human stem cell factor improves survival and cardiac function post-myocardial infarction in mice by promoting neovascularization and reducing apoptosis.
No takes yet. Share an insight, caveat, or question.
Should not alter post-MI care; hypothesis-generating in mice and leaves open translation to larger species or humans.
Xiang et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: